Premium
Letter: can addition of an immunomodulator really reverse antibody formation and loss of response in patients treated with adalimumab?
Author(s) -
Bendtzen K.,
Steenholdt C.
Publication year - 2017
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13921
Subject(s) - medicine , adalimumab , antibody response , antibody , immunology , dermatology , tumor necrosis factor alpha